Getinge-EXCH receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Getinge AB ser. B (0GZV)
Getinge AB ser. B stock price live, this page displays BS GETIBs stock exchange data. View the GETIBs premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Getinge AB ser. B real time stock price chart below.
What Is the Getinge AB ser. B Stock Price Today?
The Getinge AB ser. B stock price today is 199.48.
What Is the Stock Symbol for Getinge AB ser. B?
The stock symbol for Getinge AB ser. B is ""GETIBs.""
What Stock Exchange Does Getinge AB ser. B Trade On?
Getinge AB ser. B is listed and trades on the BATS Europe stock exchange.
Is Getinge AB ser. B a Good Stock to Buy?
Determining whether Getinge AB ser. B—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GETIBs quote. (ISIN: SE0000202624)
What Is the Getinge AB ser. B Stock Price Today?
The Getinge AB ser. B stock price today is 199.48.
What Is the Stock Symbol for Getinge AB ser. B?
The stock symbol for Getinge AB ser. B is ""GETIBs.""
What Stock Exchange Does Getinge AB ser. B Trade On?
Getinge AB ser. B is listed and trades on the BATS Europe stock exchange.
Is Getinge AB ser. B a Good Stock to Buy?
Determining whether Getinge AB ser. B—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GETIBs quote. (ISIN: SE0000202624)
199.48
-1.68(-0.84%)
Closed·
Fair Value
An estimate of a Getinge AB ser. B's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
198.25
200.50
52 wk Range
164.55
232.20
0GZV Scorecard
Full Analysis
Has raised its dividend for 6 consecutive years
Unusual trading volume
Fair Value
An estimate of a Getinge AB ser. B's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
198.25200.50
52 wk Range
164.55232.20
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.31%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.31%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
0GZV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Getinge AB ser. B's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
- Getinge-EXCH receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Getinge-EXCH receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Getinge-EXCH receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Getinge-EXCH receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Getinge-EXCH receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Getinge AB ser. B Company Profile
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It provides extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company offers surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, vascular and cardiothoracic surgery equipment, peripheral stenting, OEM solutions, and beating heart surgery equipment; and operating room equipment, anesthesia, advanced patient monitoring, and operating room integration solutions. Further, it provides pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices, and patient flow management; and low temperature sterilization, biocontainment in vaccine production, terminal sterilization, sterile isolation technology, cleaning and sterilization, aseptic transfer, and large-scale cultivation. Additionally, the company provides bioreactor preparation solution, bioprocess development and optimization, labware cleaning and sterilization, biocontainment, and vivarium. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.
Compare 0GZV to Peers and Sector
Metrics to compare | 0GZV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship0GZVPeersSector | |
|---|---|---|---|---|
P/E Ratio | 36.9x | 29.1x | −0.5x | |
PEG Ratio | −0.87 | 0.02 | 0.00 | |
Price/Book | 1.9x | 2.4x | 2.6x | |
Price / LTM Sales | 1.5x | 2.3x | 3.2x | |
Upside (Analyst Target) | - | 0.0% | 41.4% | |
Fair Value Upside | Unlock | 20.6% | 6.0% | Unlock |
Earnings
Latest Release
Jul 18, 2025
EPS / Forecast
2.25 / 1.83
Revenue / Forecast
8.64B / 8.22B
People Also Watch
FAQ
What Stock Exchange Does Getinge AB ser. B Trade On?
Getinge AB ser. B is listed and trades on the London Stock Exchange stock exchange.
What Is the Stock Symbol for Getinge AB ser. B?
The stock symbol for Getinge AB ser. B is "0GZV."
What Is the Getinge AB ser. B Market Cap?
As of today, Getinge AB ser. B market cap is 54.91B.
What Is Getinge AB ser. B's Earnings Per Share (TTM)?
The Getinge AB ser. B EPS (TTM) is 5.47.
When Is the Next Getinge AB ser. B Earnings Date?
Getinge AB ser. B will release its next earnings report on 20 Oct 2025.
From a Technical Analysis Perspective, Is 0GZV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Getinge AB ser. B Stock Split?
Getinge AB ser. B has split 0 times.
How Many Employees Does Getinge AB ser. B Have?
Getinge AB ser. B has 11874 employees.
What is the current trading status of Getinge AB ser. B (0GZV)?
As of 27 Jul 2025, Getinge AB ser. B (0GZV) is trading at a price of 199.48, with a previous close of 201.15. The stock has fluctuated within a day range of 198.25 to 200.50, while its 52-week range spans from 164.55 to 232.20.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.